Table of contents
August 2006 Volume 3 No 8
Editorial
Viewpoint
Should we incorporate psychological care into the management of IBD?
416The role of psychological distress in provoking and exacerbating IBD is controversial. This Viewpoint discusses the role of psychological factors in the pathogenesis of IBD and focuses on the need for including psychological care in the clinical management of patients with IBD.
Research Highlights
Immunosuppressive therapy in adolescent liver transplant recipients
418doi:10.1038/ncpgasthep0529 | Full Text | PDF (100K)
An NSAID plus a PPI reduces risk of dyspepsia in patients with arthritis
418Serum resistin and leptin levels predict severity of acute pancreatitis
418Promising results for multiple band ligation of prolapsed rectal mucosa
419doi:10.1038/ncpgasthep0532 | Full Text | PDF (100K)
Antioxidants help relieve pain and improve quality of life for chronic pancreatitis patients
419True upper normal limit of serum ALT is lower than usually claimed
420doi:10.1038/ncpgasthep0534 | Full Text | PDF (101K)
Atorvastatin is safe and effective for dyslipidemic patients with NAFLD
420Antifungal prophylaxis lowers risk of death after liver transplantation
421doi:10.1038/ncpgasthep0535 | Full Text | PDF (102K)
Oat inclusion in the diet of children with celiac disease
421A novel explanation for the role of dietary fiber in colorectal cancer
421Open-access endoscopy has no impact on early detection of esophagogastric cancer
422doi:10.1038/ncpgasthep0539 | Full Text | PDF (102K)
Could MELD be improved by incorporating serum sodium level?
423doi:10.1038/ncpgasthep0541 | Full Text | PDF (102K)
Practice Points
Is it safe to raise the age threshold for urgent endoscopy in patients with uncomplicated dyspepsia?
424Serum hepatitis B virus DNA level as a risk predictor for liver disease complications
426doi:10.1038/ncpgasthep0561 | Full Text | PDF (101K)
Should PPIs be given to patients on antiplatelet drugs?
428How effective are 3-month and 12-month predictive models of mortality after first liver transplantation?
430doi:10.1038/ncpgasthep0554 | Full Text | PDF (100K)
How useful is methylglucamine diatrizoate solution in patients with small-bowel obstruction?
432doi:10.1038/ncpgasthep0555 | Full Text | PDF (101K)
What is the clinical benefit of portal vein embolization before extended hepatectomy for biliary cancer?
434doi:10.1038/ncpgasthep0552 | Full Text | PDF (103K)
Reviews
Treatment options for the eradication of intestinal protozoa
436Pathogenic intestinal protozoa are responsible for clinically important infections in both the developed and developing world. Treatments have been available for several decades for giardiasis, isosporiasis and amoebiasis, but until recently there were no effective remedies for the intestinal coccidia—cyptosporidium, microsporidium and cyclospora. In this Review, the author discusses the various pathogenic intestinal protozoa and the treatment options available.
doi:10.1038/ncpgasthep0557 | Full Text | PDF (193K)
Treatment of chronic hepatitis B
446The treatment of chronic hepatitis B has improved substantially in recent years. FDA-approved therapies now include interferon 
, pegylated interferon 2a, lamivudine, adefovir dipivoxil, and entecavir. Other antiviral agents and combination regimens are in various stages of development. This Review summarizes the results obtained for approved therapies and highlights emerging antiviral agents for the treatment of chronic hepatitis B.
doi:10.1038/ncpgasthep0550 | Full Text | PDF (256K)
Technology Insight: photodynamic therapy for cholangiocarcinoma
459Cholangiocarcinoma is, in most cases, rapidly fatal, having an inadequate response to the treatment strategies currently available. The authors of this Review describe the mechanism of action, efficacy and complications of photodynamic therapy—a relatively new local, minimally invasive treatment for cholangiocarcinoma that uses the photo-physical properties of photosensitizers to destroy tumors.
doi:10.1038/ncpgasthep0543 | Full Text | PDF (320K)
Case Study
A patient with abdominal pain and markedly elevated transaminase levels after cholecystectomy
468doi:10.1038/ncpgasthep0556 | Full Text | PDF (386K)
